Stockscreener 앱 받기
0.6656
0.66%
-0.0044
시간 외 거래:
.67
0.0044
+0.66%
Adicet Bio Inc 주식(ACET)의 최신 뉴스
Adicet Bio, Inc. (NASDAQ:ACET) Shares Acquired by JPMorgan Chase & Co. - Defense World
Reviewing Adicet Bio (NASDAQ:ACET) and HUTCHMED (NASDAQ:HCM) - Defense World
Renaissance Technologies LLC Has $882,000 Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Yahoo Finance
Adicet Bio (NASDAQ:ACET) Rating Increased to Hold at StockNews.com - Defense World
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - BioSpace
Adicet Bio Announces Oral Presentation Highlighting Preclinical Adi-270 Data At The American Society Of Gene And Cell Therapy 28Th Annual Meeting - marketscreener.com
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate - Yahoo Finance
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Price Target at $7.50 - Defense World
JMP maintains Market Perform on Adicet Bio shares By Investing.com - Investing.com Canada
JMP maintains Market Perform on Adicet Bio shares - Investing.com
Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World
Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada
Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace
Adicet Bio appoints Michael Grissinger to its board - Investing.com
Adicet Bio Appoints Michael Grissinger to Board - TipRanks
Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com
Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan
Norges Bank Acquires Shares of 429,550 Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
Adicet Bio faces potential Nasdaq delisting over share price - Investing.com
Virtu Financial LLC Purchases New Stake in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference - BioSpace
Adicet Bio Strengthens Team with Strategic Stock Options Package for Key New Hires - Stock Titan
Adicet Bio Reveals Next-Gen CAR-T Strategy for Autoimmune Diseases at Major Conference - Stock Titan
Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Consensus Target Price from Brokerages - Defense World
The Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi and ACET ($ACT) Drive Blockchain Payment Innovation in UAE’s $3.9 Billion USD Initiative - GlobeNewswire Inc.
Adicet Bio (NASDAQ:ACET) Earns “Buy” Rating from Guggenheim - The AM Reporter
Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
Guggenheim Reiterates Buy Rating for Adicet Bio (NASDAQ:ACET) - Defense World
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
ACET Stock Dips to 52-Week Low at $0.74 Amid Market Challenges - Investing.com
Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 16.9% - Defense World
Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com Canada
Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa
Adicet Bio (ACET) Expected to Announce Earnings on Tuesday - Defense World
0.39%
3.66%
자본화:
|
볼륨(24시간):